Equities

ZhuZhou QianJin Pharmaceutical Co Ltd

600479:SHH

ZhuZhou QianJin Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)11.09
  • Today's Change-0.11 / -0.98%
  • Shares traded6.80m
  • 1 Year change-0.36%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,9281,7761,299
Total Receivables, Net956891888
Total Inventory534599548
Prepaid expenses2611059
Other current assets, total70138122
Total current assets3,5143,5132,917
Property, plant & equipment, net594634655
Goodwill, net141414
Intangibles, net238222220
Long term investments248188191
Note receivable - long term------
Other long term assets------
Total assets4,6774,6354,060
LIABILITIES
Accounts payable294318273
Accrued expenses232214146
Notes payable/short-term debt563690395
Current portion long-term debt/capital leases222122
Other current liabilities, total431454393
Total current liabilities1,5421,6971,228
Total long term debt384560
Total debt623756477
Deferred income tax252413
Minority interest637600550
Other liabilities, total455258
Total liabilities2,2872,4181,910
SHAREHOLDERS EQUITY
Common stock429430419
Additional paid-in capital631635585
Retained earnings (accumulated deficit)1,3631,1921,146
Treasury stock - common(35)(42)--
Unrealized gain (loss)1.591.40--
Other equity, total----0.75
Total equity2,3902,2172,150
Total liabilities & shareholders' equity4,6774,6354,060
Total common shares outstanding419419419
Treasury shares - common primary issue10110
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.